- Home
- OCFT vs DRTS Comparison
OCFT vs DRTS Comparison
Compare OCFT & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFT
- DRTS
- Stock Information
- Founded
- OCFT 2015
- DRTS 2015
- Country
- OCFT China
- DRTS Israel
- Employees
- OCFT N/A
- DRTS N/A
- Industry
- OCFT Computer Software: Programming Data Processing
- DRTS Medical/Dental Instruments
- Sector
- OCFT Technology
- DRTS Health Care
- Exchange
- OCFT Nasdaq
- DRTS Nasdaq
- Market Cap
- OCFT 236.7M
- DRTS 262.6M
- IPO Year
- OCFT 2019
- DRTS N/A
- Fundamental
- Price
- OCFT $7.16
- DRTS $2.98
- Analyst Decision
- OCFT
- DRTS Strong Buy
- Analyst Count
- OCFT 0
- DRTS 2
- Target Price
- OCFT N/A
- DRTS $8.00
- AVG Volume (30 Days)
- OCFT 74.7K
- DRTS 51.5K
- Earning Date
- OCFT 05-28-2025
- DRTS 05-19-2025
- Dividend Yield
- OCFT N/A
- DRTS N/A
- EPS Growth
- OCFT N/A
- DRTS N/A
- EPS
- OCFT N/A
- DRTS N/A
- Revenue
- OCFT $260,815,958.00
- DRTS N/A
- Revenue This Year
- OCFT N/A
- DRTS N/A
- Revenue Next Year
- OCFT $6.37
- DRTS N/A
- P/E Ratio
- OCFT N/A
- DRTS N/A
- Revenue Growth
- OCFT N/A
- DRTS N/A
- 52 Week Low
- OCFT $0.87
- DRTS $1.75
- 52 Week High
- OCFT $7.38
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- OCFT 68.12
- DRTS 54.53
- Support Level
- OCFT $7.05
- DRTS $2.92
- Resistance Level
- OCFT $7.28
- DRTS $3.12
- Average True Range (ATR)
- OCFT 0.19
- DRTS 0.19
- MACD
- OCFT 0.01
- DRTS -0.01
- Stochastic Oscillator
- OCFT 76.60
- DRTS 30.00
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a technology-as-a-service provider for the financial services industry. It integrates extensive expertise in the industry with market technology to provide technology applications and technology-enabled business services to financial institutions. The integrated solutions and platforms it provides include digital banking solutions, digital insurance solutions, and the Gamma Platform, a technology infrastructure platform for financial institutions. Geographically, the company generates substantially all of its revenue from its business in the People's Republic of China (PRC).
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.